Literature DB >> 10372860

Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease.

A Misra1, P Loyalka, F Alva.   

Abstract

Liver cysts are a well-recognized feature of autosomal dominant polycystic kidney disease (ADPKD) and occur in 77% of patients more than 60 years old. Serious sequelae, however, are rare, the two most common complications being pain and cyst infections. Portal hypertension has been reported in ADPKD due to the rare presence of congenital hepatic fibrosis. We report a case of ADPKD in a patient who had portal hypertension due to distortion of portal vein and venules by extensive hepatic cysts.

Entities:  

Mesh:

Year:  1999        PMID: 10372860     DOI: 10.1097/00007611-199906000-00015

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Medical and surgical management of portal hypertension in children.

Authors:  Riccardo A Superina; Estella M Alonso
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

Review 2.  Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.

Authors:  Jessica Wen
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

3.  Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kyongtae T Bae; Cheng Tao; Robert Feldman; Alan S L Yu; Vicente E Torres; Ronald D Perrone; Arlene B Chapman; Godela Brosnahan; Theodore I Steinman; William E Braun; Michal Mrug; William M Bennett; Peter C Harris; Avantika Srivastava; Douglas P Landsittel; Kaleab Z Abebe
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-25       Impact factor: 10.614

4.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 5.  Management of portal hypertension and ascites in polycystic liver disease.

Authors:  Lucas H P Bernts; Joost P H Drenth; Eric T T L Tjwa
Journal:  Liver Int       Date:  2019-09-20       Impact factor: 5.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.